SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global ischemia reperfusion injury therapeutics market is estimated to be valued at US$ 1,582.3 million by end of 2020 and is ...

Background: Porcine genome editing has revolutionized xenotransplantation, recently enabling the first pig-to-human heart xenotransplants. However, the xeno-immune response in heart xenografts remains ...

Skin wounds from ischemia-reperfusion injuries -- tissue damage caused by blood returning to tissues after a period of oxygen deprivation -- may not heal appropriately in some patients, owing to ...

Researchers have found new methods to enhance liver transplantation success by targeting ischemia-reperfusion injury using ...

Yet, efficient treatment for cardiac ischemia/reperfusion injury is still missing in clinics. ATP release through Pannexin1 (PANX1) channels facilitates recruitment of leukocytes to the injured ...

“One of the most intractable problems in the field of organ transplantation remains the nationwide shortage of donor livers, ...

As a complement to other biomarkers, the cytokine may aid in the decision to send patients home from the ED or admit them.

Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when blood flow is restored following a stroke. As many as one in four people ...

Cardioprotection refers to any intervention which seeks to decrease the risk of developing any adverse cardiovascular event; namely preserving the function of the heart by reducing or preventing ...

Ischemia, which in modern Latin means, “staunching of blood,” is a medical condition in which the blood supply is cut off to different parts of the body. In patients who are bed-ridden, ischemia can ...